Defence Therapeutics Inc.
DTC
Rangering i aksjer
#29442
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Aksjekurs
$0.26788696
Markedsverdi
$20.30M
Endring (1 dag)
-3.95%
Endring (1 år)
-54.23%
Land
CA
Handel Defence Therapeutics Inc. (DTC)
Kategori
Healthcare
Historikk for aksjesplitt for Defence Therapeutics Inc. (DTC)
Aksjen Defence Therapeutics Inc. (symbol: DTC) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 20, 2026.
Én DTC-aksje kjøpt før Oct 20, 2026 tilsvarer i dag 0 DTC-aksjer.
Den nyeste splittelsen skjedde Oct 20, 2026.
Én DTC-aksje kjøpt før Oct 20, 2026 tilsvarer i dag 0 DTC-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
